Accuracy In the Diagnosis Of Left Ventricular Dysfunction In Primary Care
Country of origin: UK
Click for Full Details: www.biomedcentral.comResearch was carried out to assess the accuracy of findings from the clinical history, symptoms, signs and diagnostic tests (ECG, CXR and natriuretic peptides) in relation to the diagnosis of left ventricular systolic dysfunction (LVSD) in a primary care setting.
In a diagnostic accuracy systematic review, the researchers searched Medline (1966 to March 2008), EMBASE (1988 to March 2008), Central, Cochrane and ZETOC using a diagnostic accuracy search filter. They included cross-sectional or cohort studies that assess the diagnostic utility of clinical history, symptoms, signs and diagnostic tests, against a reference standard of echocardiography. We calculated pooled positive and negative likelihood ratios and assessed heterogeneity using the I2 index.
24 studies incorporating 10,710 patients were included. The median prevalence of LVSD was 29.9% (inter-quartile range 14% to 37%). No item from the clinical history or symptoms provided sufficient diagnostic information to "rule in" or "rule out" LVSD. Displaced apex beat shows a convincing diagnostic effect with a pooled positive likelihood ratio of 16.0 (8.2?30.9) but this finding occurs infrequently in patients. ECG was the most widely studied diagnostic test, the negative likelihood ratio ranging from 0.06 to 0.6. Natriuretic peptide results were strongly heterogeneous, with negative likelihood ratios ranging from 0.02 to 0.80.
Findings from the clinical history and examination are insufficient to "rule in" or "rule out" a diagnosis of LVSD in primary care settings. BNP and ECG measurement appear to have similar diagnostic utility and are most useful in "ruling out" LVSD with a normal test result when the probability of LVSD is in the intermediate range.
Full text of the BMC Family Practice article is available online.
Click for Full Details: www.biomedcentral.com
ACC Statin Intolerance App October 2018
Sublux radiology app for all medical providers October 2018
ASCVD Risk Estimator Plus May 2018
Calculate by QxMD March 2018
ECG Guide QxMD Medical Software March 2018
Read by QxMD March 2018
Orlive Surgical Broadcasts February 2018
AnticoagEvaluator January 2018
Cardiology Advisor app January 2018